Article snapshot taken from Wikipedia with creative commons attribution-sharealike license.
Give it a read and then ask your questions in the chat.
We can research this topic together.
Venombin A (EC3.4.21.74, alpha-fibrinogenase, habutobin, zinc metalloproteinase Cbfib1.1, zinc metalloproteinase Cbfib1.2, zinc metalloproteinase Cbfib2, ancrod) is an enzyme. This enzyme catalyses the following chemical reaction
Selective cleavage of Arg- bond in fibrinogen, to form fibrin, and release fibrinopeptide A. The specificity of further degradation of fibrinogen varies with species origin of the enzyme
Venombin A enzymes are the sole representatives of the defibrinogenating agent class of drugs, which by its protease action removes fibrinogen from the circulation. They are thought to act as an antithrombotic by depletion of fibrinogen. They are different from thrombin in that they only cleave fibrinogen alpha chain (those do cleave both chains are called venombin AB), which will end up only producing weak, urea-soluble microthrombi that is easily removed by plasmin. Their benefit in acute ischaemic stroke is not supported by available evidence.
Alternatively, batroxobin is also used as a topical hemostatic by its rapid local clot-expansion action.
References
Nolan C, Hall LS, Barlow GH (1976). "Ancrod, the coagulating enzyme from Malayan pit viper (Agkistrodon rhodostoma) venom". Part B: Proteolytic Enzymes. Methods in Enzymology. Vol. 45. pp. 205–13. doi:10.1016/s0076-6879(76)45020-6. ISBN978-0-12-181945-3. PMID1011992.
Simmons G, Bundalian M, Theodor I, Martinoli J, Pirkle H (November 1985). "Action of crotalase, an enzyme with thrombin-like and kallikrein-like specificities, on tripeptide nitroanilide derivatives". Thrombosis Research. 40 (4): 555–61. doi:10.1016/0049-3848(85)90292-0. PMID2934864.
Kelton, JG; Smith, JW; Moffatt, D; Santos, A; Horsewood, P (1999). "The interaction of ancrod with human platelets". Platelets. 10 (1): 24–9. doi:10.1080/09537109976310. PMID16801067.